Refractory Glaucoma Clinical Trial
Official title:
Ahmed Glaucoma Valve Alone,With Amniotic Membrane or With MMC for Treatment of Refractory Glaucoma
This randomized, controlled trial (RCT) compares the efficacy and safety of Ahmed Glaucoma Valve (AGV) implantation alone, with 3 minutes MMC application or with a single layer coverage of amniotic membrane. Outcomes include intraocular eye pressure (IOP), postoperative glaucoma medication and complications. AGV implantation site will be superior or inferior based on indication and these groups will be randomized separately.
n/a
Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01128699 -
Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma
|
Phase 3 | |
Completed |
NCT05521334 -
MicroPulse Transscleral Laser Cyclophotocoagulation With the Zig Zag Mode in Glaucoma.
|
N/A | |
Recruiting |
NCT00349414 -
Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma
|
Phase 1/Phase 2 | |
Recruiting |
NCT04921098 -
CPC in Adult Refractory Glaucoma
|
N/A | |
Completed |
NCT01404364 -
Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye
|
N/A | |
Completed |
NCT00971061 -
Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma
|
Phase 3 | |
Not yet recruiting |
NCT05230355 -
Comparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory Glaucoma
|
N/A | |
Completed |
NCT04303897 -
Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma
|